Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

QuidelOrtho Makes Correction To 2024 Guidance To Widen Range For Adj EPS To Align With Adj EBITDA Guidance; Now Sees Adj EPS Of $1.88-$3.60 Vs . February 13 Outlook Of $2.40-$3.07 (Est $3.74)

Author: Benzinga Newsdesk | February 16, 2024 08:09am

On February 13, 2024, QuidelOrtho ssued a press release announcing the financial results for its fourth quarter and full year ended December 31, 2023, which included QuidelOrtho’s fiscal year 2024 financial guidance. QuidelOrtho is furnishing Current Report on Form 8-K to make a correction to its 2024 Guidance to widen the range for adjusted diluted EPS to align with 2024 Guidance for adjusted EBITDA, for which the mid-point of the adjusted diluted EPS range remains unchanged.

Posted In: QDEL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist